infections
Ebola Vaccine
Administration of Ebola Vaccine
rVSV-ZEBOV is given as a single injection into a muscle in people 18 years of age and older. This vaccine is recommended for people 18 years of age and older in the United States who are at high risk of occupational exposure to Ebola because they are doing the following: Responding to an outbreak of Ebola virus disease Working as health care personnel at federally designated Ebola treatment centers in the United States Working as laboratory personnel or as other staff at biosafety level 4 facilities where live Ebola virus is handled in the United States Working as laboratory personnel or as other staff at Laboratory Response Network facilities This vaccine is also stockpiled in Switzerland for rapid distribution to people in regions where an outbreak of Ebola virus disease is occurring. Ad26.ZEBOV/MVA-BN-Filo is given as an injection into a muscle in a 2-dose series for the prevention of Ebola virus disease caused by theZaire ebolavirusspecies in people 1 year of age and older. 